Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry

Acetylsalicylic acid (ASA), also known as aspirin, appears to be ineffective in inhibiting platelet aggregation in 20–30% of patients. Light transmission aggregometry (LTA) is a gold standard platelet function assay. In this pilot study, we used LTA to personalize ASA therapy ex vivo in atherosclero...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diagnostics (Basel)
Asıl Yazarlar: Khan, Hamzah, Gallant, Reid C., Zamzam, Abdelrahman, Jain, Shubha, Afxentiou, Sherri, Syed, Muzammil, Kroezen, Zachary, Shanmuganathan, Meera, Britz-McKibbin, Philip, Rand, Margaret L., Ni, Heyu, Al-Omran, Mohammed, Qadura, Mohammad
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: MDPI 2020
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7693608/
https://ncbi.nlm.nih.gov/pubmed/33114560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/diagnostics10110871
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller